Clinical Trials Logo

Primary Mitochondrial Diseases clinical trials

View clinical trials related to Primary Mitochondrial Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04548843 Not yet recruiting - Clinical trials for Primary Mitochondrial Diseases

A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion

Start date: March 2022
Phase: Phase 1
Study type: Interventional

The study objectives are to evaluate the safety of a single intravenous (IV) infusion of autologous CD34+ cells enriched with placenta-derived allogeneic mitochondria in participant with primary mitochondrial disease associated with mitochondrial DNA mutations or deletions. 6 participants aged from 4 to 18 years old on the day of screening visit with primary mitochondrial disease associated with mitochondrial DNA mutations or deletions will be enrolled.